21.19
Precedente Chiudi:
$23.37
Aprire:
$22.77
Volume 24 ore:
3.49M
Relative Volume:
2.32
Capitalizzazione di mercato:
$1.99B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
33.63
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
-8.78%
1M Prestazione:
-6.07%
6M Prestazione:
+27.57%
1 anno Prestazione:
-34.80%
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Confronta PGNY con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PGNY
Progyny Inc
|
21.19 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
![]()
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
2024-11-13 | Downgrade | Truist | Buy → Hold |
2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2024-01-03 | Iniziato | Barclays | Overweight |
2023-09-27 | Iniziato | Canaccord Genuity | Buy |
2023-05-22 | Iniziato | BTIG Research | Buy |
2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2022-09-07 | Iniziato | Truist | Buy |
2021-12-02 | Iniziato | Jefferies | Buy |
2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
2021-09-30 | Iniziato | Berenberg | Buy |
2021-08-12 | Iniziato | Barclays | Overweight |
2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
2021-04-29 | Ripresa | JP Morgan | Overweight |
2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-07-01 | Iniziato | SVB Leerink | Outperform |
2020-06-02 | Iniziato | Guggenheim | Buy |
2019-11-19 | Iniziato | Citigroup | Buy |
2019-11-19 | Iniziato | Goldman | Buy |
2019-11-19 | Iniziato | JP Morgan | Overweight |
2019-11-19 | Iniziato | Piper Jaffray | Overweight |
2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
PGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance Raised - Yahoo Finance
Progyny, Inc. Reports Strong Q1 2025 Results - TipRanks
Progyny Inc (PGNY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions - Yahoo
Earnings call transcript: Progyny Q1 2025 beats EPS estimates - Investing.com
Progyny: Q1 Earnings Snapshot - Norwalk Hour
Progyny Q1 2025 Earnings Call Transcript - MarketBeat
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Progyny Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Progyny, Inc. Q1 Profit Beats Estimates - Nasdaq
Progyny (PGNY) Surpasses Q1 Revenue Expectations with Robust Growth | PGNY Stock News - GuruFocus
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q1, Provides Optimistic Revenue Guidance for Next Quarter - Yahoo Finance
Progyny, Inc. Announces First Quarter 2025 Results - The Manila Times
(PGNY) PROGYNY INC. Forecasts Q2 Revenue Range $310M$325M - marketscreener.com
Progyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Progyny (PGNY) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
BlackRock, Inc. Adjusts Holdings in Progyny Inc: A Strategic Portfolio Move - GuruFocus
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building - ADVFN
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Progyny: Q3 Earnings Snapshot - marketscreener.com
At US$22.90, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely? - simplywall.st
Progyny, Inc. Announces Details for Its First Quarter 2025 Resul - GuruFocus
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report - The Manila Times
Progyny, Inc. to Report Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Progyny Sets Date for Q1 2025 Earnings: What Fertility Healthcare Investors Should Watch - Stock Titan
(PGNY) Technical Data - news.stocktradersdaily.com
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Progyny Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Progyny Rings the Opening Bell - Nasdaq
Progyny names Melissa Cummings as COO - MSN
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny (PGNY) Boosts Leadership Team with COO and Chief Product - GuruFocus
Progyny names new COO and CPO to drive growth By Investing.com - Investing.com India
Progyny Names Melissa Cummings COO - marketscreener.com
Progyny names new COO and CPO to drive growth - Investing.com
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | PGNY Stock News - GuruFocus
Progyny Names Healthcare Veterans Melissa Cummings as Chief - GlobeNewswire
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer - TradingView
Progyny to Host Events Honoring Individuals, Families and Infert - GuruFocus
Progyny to Host Events Honoring Individuals, Families and - GlobeNewswire
Progyny Takes Over Nasdaq & Empire State Building for Groundbreaking Fertility Awareness Week - Stock Titan
Progyny announces director Dr. Fred Cohen to step down By Investing.com - Investing.com Canada
Form DEFA14A Progyny, Inc. - StreetInsider
Progyny announces director Dr. Fred Cohen to step down - Investing.com Australia
Progyny Director Fred Cohen to Step Down - TipRanks
SEC Form DEFA14A filed by Progyny Inc. - Quantisnow
Progyny, Inc. Announces Fred E. Cohen Notifies the Board of Directors of His Decision Not to Stand for Reelection At the 2025 Annual Meeting of Stockholders - marketscreener.com
Assisted Reproductive Technology Market Forecast Report and Company Analysis 2025-2033 Featuring Thermo Fisher Scientific, Sumitomo Mitsui, CooperSurgical, Fujifilm, Merck, Progyny, Cosmos BiomedicalResearchAndMarkets.com - Bluefield Daily Telegraph
The Broken Brown Egg and Progyny Announce the 2025 - GlobeNewswire
Major Fertility Support: Progyny's New Grant Removes Barriers for BIPOC Family Building - Stock Titan
Progyny's SWOT analysis: fertility benefits provider faces growth hurdles - Investing.com
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):